[1
]
Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle
upon Tyne, UK.
[2
]
Medical Research Council Clinical Trials Unit at University College London, London,
UK.
[3
]
Queen's Centre for Oncology and Haematology, Castle Hill Hospital, Hull, UK.
[4
]
Institute of Cancer Sciences, The University of Manchester, Manchester Academic Health
Science Centre, The Christie NHS Foundation Trust, Manchester, UK.
[5
]
Bristol Haematology and Oncology Centre, Bristol, UK.
[6
]
Newcastle Clinical Trials Unit and Institute of Health and Society, Newcastle University,
Newcastle upon Tyne, UK.
[7
]
Wales Cancer Research Network, Cardiff UK.
[8
]
The Beatson West of Scotland Cancer Centre, Greater Glasgow Health Board and Clyde,
Glasgow, UK.
[9
]
Patient representative, Manchester, UK.
[10
]
Trans Tasman Radiation Oncology Group, Waratah, NSW, Australia; University of Queensland,
QLD, Australia.
[11
]
Nottingham University Hospital, Nottingham, UK.
[12
]
Weston Park Hospital, Sheffield, UK.
[13
]
Queen Elizabeth Hospital, Kings Lynn, UK.
[14
]
Medical Research Council Clinical Trials Unit at University College London, London,
UK. Electronic address: ruth.langley@ucl.ac.uk.